21-166
Showing 1 - 25 of 6,793
Liver Metastases, Breast Cancer Trial in Leuven, Amsterdam (Quiremspheres™)
Recruiting
- Liver Metastases
- Breast Cancer
- Quiremspheres™
-
Leuven, Vlaams-Brabant, Belgium
- +1 more
Nov 16, 2023
Effectiveness in Patients With Metabolic Syndrome (TRISTAN)
Completed
- Hypertriglyceridemia
- Metabolic Syndrome
- Tricor (fenofibrate), 145 mg, film-coated tablet
-
Barnaul, Russian Federation
- +62 more
Dec 14, 2021
Respiratory Syncytial Virus Trial in Worldwide (Ad26.RSV.preF, Placebo, Nimenrix)
Completed
- Respiratory Syncytial Virus
- Ad26.RSV.preF
- +2 more
-
Geelong, Australia
- +24 more
Nov 23, 2021
Hepatocellular Carcinoma Non-resectable Trial (Holmium-166 radioembolization)
Recruiting
- Hepatocellular Carcinoma Non-resectable
- Holmium-166 radioembolization
-
Utrecht, NetherlandsUMC Utrecht
Nov 7, 2022
Schizophrenia Trial in Worldwide (SEP-363856 75mg, SEP-363856 100mg, Placebo)
Recruiting
- Schizophrenia
- SEP-363856 75mg
- +2 more
-
Little Rock, Arkansas
- +63 more
Dec 12, 2022
Liver Cancer, Liver Metastasis Colon Cancer, Primary Liver Cancer Trial (Fractional administration device)
Not yet recruiting
- Liver Cancer
- +2 more
- Fractional administration device
- (no location specified)
Jan 13, 2022
Amyotrophic Lateral Sclerosis Trial in Charlotte (Placebo (for MN-166), MN-166, riluzole)
Completed
- Amyotrophic Lateral Sclerosis
- Placebo (for MN-166)
- +2 more
-
Charlotte, North CarolinaCarolinas Healthcare System, Dept. of Neurology
Oct 7, 2021
Delinquency, Drug Use Trial in Eugene (Treatment Foster Care (TFCO), Group Care)
Completed
- Delinquency
- Drug Use
- Treatment Foster Care (TFCO)
- Group Care
-
Eugene, Oregon
- +1 more
Feb 23, 2022
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)
Active, not recruiting
- Glioblastoma
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 16, 2022
Holmium-166 Retrospective Collection of Real-World Data
Completed
- Hepatocellular Carcinoma
- Metastatic Cancer
- Selective Internal Radiation Therapy with QuiremSpheresTM Holmium-166 Microspheres
-
Aalst, Belgium
- +11 more
Aug 29, 2022
Pancreas Cancer Trial in Nijmegen (Intratumoral)
Recruiting
- Pancreas Cancer
- Intratumoral
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Centre
May 19, 2023
Peanut Allergy Trial in Worldwide (Viaskin Peanut 250 mcg, Viaskin Peanut 100 mcg, Placebo)
Active, not recruiting
- Peanut Allergy
- Viaskin Peanut 250 mcg
- +2 more
-
Tucson, Arizona
- +50 more
Apr 23, 2021
Primary Liver Cancer, Non-Resectable Hepatocellular Carcinoma Trial (MRI-guided radioembolization)
Not yet recruiting
- Primary Liver Cancer
- Non-Resectable Hepatocellular Carcinoma
- MRI-guided radioembolization
- (no location specified)
Nov 1, 2022
Diabetic Nephropathies Trial in Worldwide (Finerenone (BAY94-8862), Placebo)
Completed
- Diabetic Nephropathies
- Finerenone (BAY94-8862)
- Placebo
-
Birmingham, Alabama
- +146 more
Jun 30, 2021
Dry Eye Disease Trial in United States (CyclASol topical ocular, eye drops, Vehicle topical ocular, eye drops)
Completed
- Dry Eye Disease
- CyclASol topical ocular, eye drops
- Vehicle topical ocular, eye drops
-
Newport Beach, California
- +8 more
Dec 21, 2022
Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)
Active, not recruiting
- Renal Cell Carcinoma
- Cabozantinib
- +3 more
-
La Jolla, California
- +159 more
Jan 23, 2023
Diabetes Trial in Al Madinah, Riyadh (Home Healthcare)
Completed
- Diabetes Mellitus
- Home Healthcare
-
Al Madinah, Saudi Arabia
- +1 more
Jun 23, 2023
OCD, Anxiety Disorders, Pediatric Disorder Trial in Riverside (Exposure Therapy)
Recruiting
- Obsessive-Compulsive Disorder
- +13 more
- Exposure Therapy
-
Riverside, Rhode IslandBradley Hospital
Aug 2, 2022
Serum Magnesium Level in Type 2 Diabetes Mellitus
Not yet recruiting
- Diabetes Mellitus
- Magnesium
-
Sohag, EgyptSohag university Hospital
Sep 22, 2023
Physical Activity, Diet Modification Trial in Bath (Diet)
Completed
- Physical Activity
- Diet Modification
- Diet
-
Bath, United KingdomDepartment for Health, University of Bath
Oct 7, 2022